Delivery Order SPE2DB22D3501-SPE2DB23FXJ02

Award Date 9/25/23
Potential Completion Date 10/17/23
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $62,827.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562096738 GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the intravenous immunoglobulin product from its facility in Conshohocken, Pennsylvania to fulfill requirements under the contract. Funding is provided by the Defense Logistics Agency to support its medical supply chain initiatives....
The Defense Logistics Agency Troop Support Medical awarded a $4,262 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562088405 GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 7, 2023 through September 28, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply intravenous immunoglobulin products in support of the Defense...
The Defense Logistics Agency awarded a $22,540.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562215073 GAMUNEX-C 10 GRAM/100 ML VIAL 100ML. The place of performance is Conshohocken, Pennsylvania. The start date is September 18, 2023 and end date is October 10, 2023. This delivery order is likely placed against DLA's Pharmaceutical Prime Vendor contract, which provides pharmaceuticals and other medical supplies to support the Department of Defense's healthcare...
The Defense Logistics Agency awarded a $2,247.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561666910 GAMUNEX-C 1 GRAM/10 ML VIAL 10ML. The place of performance is Conshohocken, Pennsylvania. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply the Defense Logistics Agency's medical product requirements. No subcontractors or set-aside designations were identified. The delivery order has a period of performance...
The Defense Logistics Agency awarded a $1,697.10 delivery order to Amerisourcebergen Drug Corporation for 4561784942 GAMUNEX-C 5 GRAM/50 ML VIAL 50ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide intravenous immunoglobulin to support DLA and Department of Defense needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 11th through September 1st, 2023. No subcontractors or...
The Defense Logistics Agency Troop Support Medical awarded a $6,393.24 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561357506 GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on June 27, 2023 and ending on July 19, 2023. This delivery order was awarded under an existing indefinite-delivery/indefinite-quantity contract...
The Defense Logistics Agency Troop Support Medical awarded a $21,310.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for 4561787140 GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The place of performance is Conshohocken, Pennsylvania, with work scheduled to be completed by September 1, 2023 after starting on August 11th of this year. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by...
The Defense Logistics Agency awarded a $102,291.84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562356290 GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the products from its location in Conshohocken, Pennsylvania to fulfill the requirements under this order issued from September 29, 2023 through October 23, 2023. As the Defense Logistics Agency is responsible for worldwide...
The Defense Logistics Agency awarded a $16,883.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561624549 GAMUNEX-C 10 GRAM/100 ML VIAL 100ML. The place of performance is Conshohocken, Pennsylvania. The start date is July 27, 2023 and end date is August 17, 2023. This delivery order is likely associated with the Defense Logistics Agency's Prime Vendor Program, through which it obtains pharmaceuticals and medical supplies for various Department of Defense...
The Defense Logistics Agency awarded a $2,247.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 gram per 10 milliliter vials of GAMUNEX-C, a human normal immunoglobulin preparation. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on August 21, 2023 and ending on September 12, 2023. No major subcontractors or set aside designations were identified. The...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FXJ02
    Delivery Order

The Defense Logistics Agency awarded a $16,883.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562293559 GAMUNEX-C 10 GRAM/100 ML VIAL 100ML. The place of performance is Conshohocken, Pennsylvania. The start date is September 25, 2023 and end date is October 17, 2023. This delivery order is likely associated with DLA's prime vendor program, under which Amerisourcebergen supplies pharmaceutical products to DOD customers. No subcontractors or set aside designations were identified. The award will deliver intravenous immunoglobulin to support DOD medical readiness and personnel health programs over the approximately three week period of performance.

Generated 12/25/23, 9:15 AM